<DOC>
	<DOC>NCT00328978</DOC>
	<brief_summary>The purpose of the study is to assess and compare the side effect profile, safety, tolerability and efficacy of schizophrenic or schizoaffective subjects non- or partially- responsive to 800 mg/day of quetiapine treated with either 800 mg/day or more than 800 mg/day of quetiapine during 8 weeks.</brief_summary>
	<brief_title>Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Men and women, age 1865 years with persistent positive or negative symptoms with a PANSS total score of â‰¥ 70 and &lt; 110 and a Clinical Global Improvement (CGI) Severity of Illness score of at least 4 (moderately ill) at screening. Subjects may be treated as in or outpatients. Subjects must give written informed consent. Subjects with other psychiatric, medical or behavioural comorbid disorder that may interfere with study conduct or interpretation. Female of childbearing potential, unless the subject is using a reliable method of contraception Subjects with alcohol or psychoactivesubstance dependence not in full remission or with significant alcohol or substance abuse in the past 3 months will be excluded. Laboratory test results outside the range of reference considered by the investigator to be clinically significant. Inability to respect the visit schedule and known intolerance to quetiapine at 800mg/day.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorders</keyword>
</DOC>